Stocks › EW

Edwards Lifesciences Corp

EW·NYSE·United States United States·USD
$101.85
-2.03 (-1.95%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
EW
Edwards Lifesciences Corp · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EWS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of EW by members of U.S. Congress · 132 on record · 13 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Stock Sale
$1,001 - $15,000
Sep 5, 2026 Aug 3, 2026 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
Jul 21, 2026 Mar 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 1, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
May 11, 2026 Apr 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Sale
$1,001 - $15,000
May 11, 2026 Apr 24, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Purchase
$1,001 - $15,000
Apr 7, 2026 Mar 23, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Sale
$1,001 - $15,000
Apr 7, 2026 Mar 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Sale
$1,001 - $15,000
Mar 9, 2026 Feb 5, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Sale
$1,001 - $15,000
Feb 6, 2026 Jan 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Stock Sale
$1,001 - $15,000
Feb 6, 2026 Jan 23, 2026 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ EWEdwards Lifesciences Corp · Stock Sale
$1,001 - $15,000
Dec 29, 2025 Nov 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Sale
$1,001 - $15,000
Nov 6, 2025 Oct 7, 2025 Filing ↗
Jefferson ShreveJefferson ShreveHouse · R · IN EWEdwards Lifesciences Corp · Stock Sale
$50,001 - $100,000
Jun 22, 2025 May 12, 2025 Filing ↗
Bruce WestermanBruce WestermanHouse · R · AR EWEdwards Lifesciences Corp · Stock Sale
$1,001 - $15,000
May 12, 2025 Apr 21, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
May 8, 2025 Apr 8, 2025 Filing ↗
Jefferson ShreveJefferson ShreveHouse · R · IN EWEdwards Lifesciences Corp · Stock Purchase
$15,001 - $50,000
May 8, 2025 Apr 7, 2025 Filing ↗
Bruce WestermanBruce WestermanHouse · R · AR EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
Apr 16, 2025 Mar 3, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Common Stock Purchase
$1,001 - $15,000
Apr 10, 2025 Mar 12, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
Dec 5, 2024 Nov 12, 2024 Filing ↗
Byron DonaldsByron DonaldsHouse · R · FL EWEdwards Lifesciences Corp · Stock Sale
$1,001 - $15,000
Nov 8, 2024 Oct 19, 2023 Filing ↗
Byron DonaldsByron DonaldsHouse · R · FL EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
Nov 8, 2024 May 5, 2021 Filing ↗
Byron DonaldsByron DonaldsHouse · R · FL EWEdwards Lifesciences Corp · Stock Sale
$1,001 - $15,000
Nov 8, 2024 Oct 19, 2023 Filing ↗
Byron DonaldsByron DonaldsHouse · R · FL EWEdwards Lifesciences Corp · Stock Purchase
$1,001 - $15,000
Nov 8, 2024 Mar 5, 2021 Filing ↗

Whale Activity

Position changes in EW reported for 2026-09-30 by 1441 institutional filers
Increased: 445New: 114Held: 249Decreased: 470Closed: 94No prior filing: 69
  • Increased445
  • New114
  • Held249
  • Decreased470
  • Closed94
  • No prior filing69
FilerSharesValueChange
BlackRock, Inc.58.7M$5.07Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC37.7M$3.26Bincreased
STATE STREET CORP26.5M$2.29Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC26.5M$2.29Bincreased
JPMORGAN CHASE & CO24.5M$2.15Bincreased
WELLINGTON MANAGEMENT GROUP LLP16.9M$1.46Bincreased
GEODE CAPITAL MANAGEMENT, LLC15.6M$1.34Bincreased
Ninety One UK Ltd11.9M$1.03Bdecreased
Bank of New York Mellon Corp11.3M$973.7Mdecreased
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main10.7M$923.7Mdecreased
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP10.2M$879.9Mincreased
Aristotle Capital Management, LLC8.1M$700.7Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by EW insiders, by quarter · Form 4
-200.0K-100.0K0100.0K200.0K2025 Q1: -73.8K2025 Q12025 Q2: -57.7K2025 Q22025 Q3: -15.6K2025 Q32025 Q4: -76.0K2025 Q42026 Q1: -84.1K2026 Q12026 Q2: -120.6K2026 Q22026 Q3: -50.8K2026 Q32026 Q4: -73.2K2026 Q4

Recent Insider Transactions

4,811 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Lippis Daniel J.CVP, TAVR Sale −619 $104.25 $65K Nov 10, 2026 Form 4 ↗
Zovighian Bernard JCEO · Director Sale −9,184 $103.39 $949K Nov 9, 2026 Form 4 ↗
Zovighian Bernard JCEO · Director Sale −13.9K $102.78 $1.4M Nov 9, 2026 Form 4 ↗
BOBO DONALD E JRCVP,Strategy/Corp Development Sale −48.9K $103.05 $5.0M Nov 9, 2026 Form 4 ↗
Lippis Daniel J.CVP, TAVR Sale −619 $85.65 $53K Oct 8, 2026 Form 4 ↗
Markowitz WayneCVP, JAPAC Tax withholding −568 $84.37 $48K Sep 14, 2026 Form 4 ↗
Dahl Andrew M.SVP, Corporate Controller Tax withholding −253 $84.37 $21K Sep 13, 2026 Form 4 ↗
Markowitz WayneCVP, JAPAC Tax withholding −355 $86.77 $31K Sep 11, 2026 Form 4 ↗
Chopra DaveenCVP, TMTT, Surgical & IHFM Tax withholding −398 $86.77 $35K Sep 11, 2026 Form 4 ↗
Lippis Daniel J.CVP, TAVR Sale −619 $87.51 $54K Sep 11, 2026 Form 4 ↗
Lippis Daniel J.CVP, TAVR Option exercise +619 $72.68 $45K Sep 11, 2026 Form 4 ↗
Dahl Andrew M.SVP, Corporate Controller Sale −544 $91.06 $50K Aug 31, 2026 Form 4 ↗
Bruls AnnetteCVP, EMEACLA Sale −2,644 $89.98 $238K Aug 28, 2026 Form 4 ↗
Chopra DaveenCVP, TMTT, Surgical & IHFM Sale −30.6K $90.99 $2.8M Aug 26, 2026 Form 4 ↗
Chopra DaveenCVP, TMTT, Surgical & IHFM Sale −1,154 $91.76 $106K Aug 26, 2026 Form 4 ↗
Chopra DaveenCVP, TMTT, Surgical & IHFM Option exercise +31.8K $72.68 $2.3M Aug 26, 2026 Form 4 ↗
Markowitz WayneCVP, JAPAC Sale −1,240 $91.47 $113K Aug 26, 2026 Form 4 ↗
Lippis Daniel J.CVP, TAVR Sale −619 $92.03 $57K Aug 11, 2026 Form 4 ↗
Lippis Daniel J.CVP, TAVR Option exercise +619 $72.68 $45K Aug 11, 2026 Form 4 ↗
Markowitz WayneCVP, JAPAC Sale −146 $86.03 $13K Jul 30, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding EW · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
18.3M$1.65B0.07%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
14.9M$1.35B0.08%Jun 30, 2026
VANGUARD MID-CAP INDEX FUND
VANGUARD INDEX FUNDS
12.5M$1.13B0.50%Jun 30, 2026
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
11.4M$977.6M2.56%Jul 31, 2026
iShares Core S&P 500 ETF
iShares Trust
7.9M$716.5M0.08%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
7.5M$678.3M0.08%Aug 31, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust7.0M$631.3M0.08%Jun 30, 2026
VANGUARD VALUE INDEX FUND
VANGUARD INDEX FUNDS
5.5M$495.3M0.19%Jun 30, 2026
VANGUARD MID-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
4.4M$399.0M1.15%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF
SELECT SECTOR SPDR TRUST
4.1M$368.0M0.91%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list EW's shares (CUSIP 28176E108), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming edwards lifesciences as client
$0$1.3M$2.5M$3.8M$5.0M2023 Q1: $590K2023 Q2: $960K2023 Q3: $490K2023 Q4: $540K20232024 Q1: $650K2024 Q2: $570K2024 Q3: $520K2024 Q4: $570K20242025 Q1: $500K2025 Q2: $510K2025 Q3: $430K2025 Q4: $500K20252026 Q1: $490K2026 Q2: $490K2026 Q3: $510K2026
  • MARSHALL & POPP, LLCEDWARDS LIFESCIENCES, LLC · 2026 Q4 · HCR, MMM, TAX, BUD—
    Filing ↗
  • AVENUE SOLUTIONSEDWARDS LIFESCIENCES LLC · 2026 Q3 · MMM$50K
    Filing ↗
  • BGR GOVERNMENT AFFAIRSEDWARDS LIFESCIENCES LLC · 2026 Q3 · HCR$50K
    Filing ↗
  • FARRAGUT PARTNERS LLPEDWARDS LIFESCIENCES, LLC · 2026 Q3 · MMM, HCR$50K
    Filing ↗
  • AKIN GUMP STRAUSS HAUER & FELDEDWARDS LIFESCIENCES LLC · 2026 Q3$60K
    Filing ↗

Government Contracts

Federal awards to edwards lifesciences · USAspending
$15.1MAwarded · 296 contracts on record
  • Department of Veterans AffairsCUSTOM SURGICAL IMPLANTS$68K
    Oct 21, 2026 · ↗
  • Department of Veterans AffairsTAVR$34K
    Nov 20, 2026 · ↗
  • Department of Veterans AffairsHEART VALVE CONSIGNMENT$34K
    Nov 20, 2026 · ↗
  • Department of Veterans AffairsHEART VALVE CONSIGNMENT$34K
    Nov 20, 2026 · ↗
  • Department of Veterans AffairsS3U RESILIA HEART VALVE$34K
    Nov 20, 2026 · ↗
  • Department of Veterans AffairsTAVR$34K
    Nov 20, 2026 · ↗
  • Department of Veterans AffairsIMPLANT$34K
    Nov 20, 2026 · ↗
  • Department of Veterans AffairsPROSTHETICS - TAVR HEART VALVES - X3$34K
    Jul 8, 2025 · ↗

U.S. Patents

Recent USPTO applications naming Edwards Lifesciences Corp

No USPTO patent applications found for Edwards Lifesciences Corp.

Annual Financials

From EW's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$6.07B$5.44B$5.01B$4.46B$5.23B
Operating income$1.26B$1.38B$1.31B$1.50B$1.69B
Net income$1.07B$4.17B$1.40B$1.52B$1.50B
Diluted EPS$1.83$6.97$2.30$2.44$2.38
Operating cash flow$1.60B$542.3M$895.8M$1.22B$1.73B
Cash and equivalents$2.94B$3.05B$1.13B$769.0M$862.8M
Total assets$13.70B$13.06B$9.36B$8.29B$8.50B
Total liabilities$3.36B$2.99B$2.64B$2.49B$2.67B
Shareholders' equity$10.34B$10.00B$6.65B$5.81B$5.84B

As Edwards Lifesciences Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 25, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 3-for-1Stock splitJun 1, 2020
  • 2-for-1Stock splitDec 14, 2015
  • 2-for-1Stock splitMay 28, 2010

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationNov 19, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 4, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeAug 28, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 23, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteMay 8, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01Officer / director change · Reg FD disclosureMay 4, 2026
    EDGAR ↗

About Edwards Lifesciences Corp

From SEC EDGAR company records
Industry (SIC 3842)Orthopedic, Prosthetic & Surgical Appliances & Supplies
SectorHealthcare
HeadquartersIRVINE, CA
IncorporatedDE
Former namesCVG CONTROLLED INC